Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Kluytmans, Jan

  • Google
  • 1
  • 4
  • 31

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (1/1 displayed)

  • 2003High Percentage of Methicillin-Resistant <i>Staphylococcus aureus</i> Isolates with Reduced Susceptibility to Glycopeptides in The Netherlands31citations

Places of action

Chart of shared publication
Griethuysen, Arjanne Van
1 / 1 shared
Veen, Annemarie Van T.
1 / 2 shared
Walsh, Timothy
1 / 3 shared
Buiting, Anton
1 / 2 shared
Chart of publication period
2003

Co-Authors (by relevance)

  • Griethuysen, Arjanne Van
  • Veen, Annemarie Van T.
  • Walsh, Timothy
  • Buiting, Anton
OrganizationsLocationPeople

article

High Percentage of Methicillin-Resistant <i>Staphylococcus aureus</i> Isolates with Reduced Susceptibility to Glycopeptides in The Netherlands

  • Griethuysen, Arjanne Van
  • Veen, Annemarie Van T.
  • Kluytmans, Jan
  • Walsh, Timothy
  • Buiting, Anton
Abstract

<jats:title>ABSTRACT</jats:title><jats:p>While testing the in vitro activities of 14 antimicrobial agents against 107 methicillin-susceptible<jats:italic>Staphylococcus aureus</jats:italic>(MSSA) and 250 methicillin-resistant<jats:italic>S. aureus</jats:italic>(MRSA) isolates collected in The Netherlands, we found to our surprise that 19 (7.6%) MRSA isolates were suspected of having reduced susceptibilities to the glycopeptides when the Etest system (AB Biodisk, Solna, Sweden) was used with a large inoculum (no. 2 McFarland standard) and an extended incubation time (48 h) on brain heart infusion agar for MIC testing. Eventually, 15 of these isolates were classified as heterogeneously resistant to glycopeptides (heterogeneously glycopeptide-intermediate<jats:italic>S. aureus</jats:italic>[hGISA] isolates) according to the population analysis profile-area under the curve analysis. The MICs at which 50 and 90% of isolates are inhibited obtained with the Etest system with the large inoculum were as follows: for MSSA isolates, 3.0 and 4.0 μg/ml, respectively, for both teicoplanin and vancomycin; for MRSA isolates, 3.0 and 8.0 μg/ml, respectively, for teicoplanin, and 3.0 and 4.0 μg/ml, respectively, for vancomycin. This is the first report of hGISA isolates in The Netherlands.</jats:p>

Topics
  • impedance spectroscopy
  • susceptibility